Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF v600 mutation–positive melanoma receiving adjuvant vemurafenib
Titel:
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF v600 mutation–positive melanoma receiving adjuvant vemurafenib
Auteur:
Ascierto, P.A. Lewis, K.D. Di Giacomo, A.M. Demidov, L. MandalĂ , M. Bondarenko, I. Herbert, C. Mackiewicz, A. Rutkowski, P. Guminski, A. Simmons, B. Ye, C. Hooper, G. Wongchenko, M.J. Goodman, G.R. Yan, Y. Schadendorf, D.